Inclisiran

Drug / Medication

A PCSK9 inhibitor used aggressively in adult FH patients.

Mentioned in 2 videos

Videos Mentioning Inclisiran

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

A PCSK9 inhibitor used aggressively in adult FH patients.

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

Peter Attia MD

A small interfering RNA (siRNA) that inhibits PCSK9 synthesis, lowering LDL by about 50%, with a convenient every-six-month dosing, but outcome data is still pending.